182
Participants
Start Date
December 10, 2021
Primary Completion Date
May 18, 2025
Study Completion Date
May 18, 2025
Ustekinumab
Ustekinumab will be administered as an IV injection in induction phase and as a SC injection in maintenance phase.
Peking University Third Hospital, Beijing
The Military General Hospital of Beijing PLA, Beijing
Shengjing Hospital Of China Medical University, Shenyang
Huashan Hospital Fudan University, Shanghai
Shanghai 10th Peoples Hospital, Shanghai
The second Xiangya Hospital of Central South University, Changsha
Shanghai East Hospital, Shanghai
Zhongda Hospital Southeast University, Nanjing
Jiangsu Province Hospital, Nanjing
Changzhou No 2 Peoples Hospital, Changzhou
Wuxi People s Hospital, Wuxi
The Second Hospital Affiliated To Suzhou University, Suzhou
Yangzhou First People's Hospital, Yangzhou
Anhui Province Hospital, Hefei
The Second Affiliated Hospital of Zhejiang University, Hangzhou
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou
Huzhou central hospital, Huzhou
Ningbo medical center lihuili hospital, Ningbo
Jinhua municipal central hospital, Jinhua
The First Affiliated Hospital of NanChang University, Nanchang
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Tongji Hospital, Tongji Medical College of HUST, Wuhan
Renmin Hospital of Wuhan University, Wuhan
The First Affiliated Hospital Sun Yat sen University, Guangzhou
Guangzhou First Municipal People's Hospital, Guangzhou
Peking University Shenzhen Hospital, Shenzhen
Affiliated Hospital of Zunyi Medical University, Zunyi
West China Hospital Sichuan University, Chengdu
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou
Janssen Research & Development, LLC
INDUSTRY